Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

CYT-003-QbG-10 is safe and efficacious in allergic asthma

Sep. 29, 2010

Phase I data presented on flu vaccine NB-1008 and acne therapy NB-003

Sep. 29, 2010

Imeglimin shows promise in phase II trials in type 2 diabetes

Sep. 29, 2010

Phase II data on MK-0941 cast doubt on suitability for treatment of diabetes

Sep. 29, 2010

Namisol tablet for multiple sclerosis shows promise in first-in-human trial

Sep. 28, 2010

E-6005 improves pruritus and inflammation in preclinical tests

Sep. 28, 2010

NexMed and Bio-Quant present preclinical data on PrevOnco

Sep. 28, 2010

Phico Therapeutics details phase I tolerability of PT1.2

Sep. 27, 2010

BI-10773 improves glycemic control in large study in type 2 diabetes

Sep. 27, 2010

Novartis reports on clinical development of LDE-225

Sep. 27, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...